about
AcromegalyClinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluationClinical importance of achieving biochemical control with medical therapy in adult patients with acromegalyNeed for improved monitoring in patients with acromegalyCurious cases: Acromegaly and schizophrenia: an incidental association?Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysisThe risks of overlooking the diagnosis of secreting pituitary adenomasIncreased prevalence of carpal tunnel syndrome in albright hereditary osteodystrophyGermline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature.Acromegaly without imaging evidence of pituitary adenoma.Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extensionClinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review.Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosedAdverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care populationChorio-retinal thickness measurements in patients with acromegalyClinical experiences and success rates of acromegaly treatment: the single center results of 62 patients.Efficacy and complications of neurosurgical treatment of acromegaly.Surgical management of acromegaly in a resource-challenged environment.Primary medical therapy for acromegaly.Modern treatment of acromegaly.Clinical, quality of life, and economic value of acromegaly disease controlInvestigation of the vitamin D receptor polymorphisms in acromegaly patients.Gene Expression Signature in Adipose Tissue of Acromegaly Patients.Pegvisomant: a novel pharmacotherapy for the treatment of acromegaly.The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth.Clinical manifestations and diagnosis of acromegalyGamma knife radiosurgery for acromegaly.The role of growth hormone-receptor antagonism in relation to acromegaly.Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis.Growth hormone and its disordersRecent developments in the therapy of acromegaly.Assessment of the magnitude of growth hormone hypersecretion in active acromegaly: reliability of different sampling models.Incidence and prevalence of acromegaly in a large US health plan databaseTreatment Patterns and Economic Burden in Patients Treated for Acromegaly in the USAReal-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databasesGrowth hormone, insulin-like growth factors, and the skeleton.Pulmonary function testing and chest tomography in patients with acromegaly.Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults.Mandibular prognathism caused by acromegaly - a surgical orthodontic case.
P2860
Q21202912-78803FFF-C47C-463D-828A-33373AA4D4D7Q21254711-1FB292C3-5039-476A-9E69-32420B8D87ADQ26741026-C7876D39-0E93-4473-AC45-353543D9CE96Q26783670-6CC109CB-557F-45F8-852F-C907BAA4B6E8Q27025160-83BA8E7B-26F9-4727-A30B-03CED10A646EQ27693237-7C847B6D-1763-4F8A-8138-BC0CE8525BACQ28076665-5B96EC5E-DCA9-4986-A25A-9ECD5A1695F2Q28390224-113E59B2-61ED-4A69-89BF-8FD115BD4285Q30235105-3CD641E5-FB5D-4E57-89F8-C88C88F8F1AFQ30314266-78C607AC-8252-4192-997B-C5C601107AD5Q30430884-04C2CD44-C35A-454E-A608-BCD91AF2945BQ33595081-56BA4481-0A2F-4122-BC87-27B097913FDDQ33772673-41522554-3102-42E6-9366-0C523C99671DQ33835825-6A7862B5-0FB4-4E5B-B617-6D30899A8B30Q34031924-82DA3150-5818-4F86-85F7-5D605F68A6FCQ34759602-4505824E-123C-4D4B-B6E2-25FCA8CAEF10Q34901376-A34D12CE-F14C-4DE1-9FFB-419308FFECF1Q34981394-BBCB5E22-A6C1-416D-AE45-FDA1DDB57132Q35041686-B7AF7B6F-49C5-4565-A2E4-4B04B6447141Q35086868-7297B021-5823-4EAD-8839-4E5E1B44497CQ35125987-6ABD0A55-6F05-4E99-BF69-D1EE0A270CA8Q35137675-0E162C04-0737-47D3-96BD-FA62915C5526Q35206714-E5ECEC88-7C43-4F1F-ABB9-FD2FE0DD41D3Q35667597-D89F57F7-4626-4333-B06A-C9D90901DE28Q35684886-923E218C-96B1-442D-816B-D9E6311215E5Q35752727-456106C5-D73B-4805-B5D7-7355C56249EFQ35810485-1EF7945C-5200-4916-8F19-BFD276B0727DQ35810502-4662E34E-6EB3-4123-A18E-2AA5DD9898EFQ35925517-D274F8A0-96DC-4605-AF1C-7F66F909A658Q36333180-BB92AC6D-0F1A-48C9-B9C3-95A49E7EF4F7Q36362200-67286186-1A42-4825-883E-DA2448349ED9Q36407309-002D27D3-AC46-4B73-8B5C-D7D7478272B3Q36459956-7F98987F-AE7F-401F-8548-C32EF175DFFFQ36874730-F751E49D-AAA0-4017-B3EE-68B844359F3DQ36942936-51693FE2-C2B4-4F82-90FF-7E83E709EBE6Q37061146-585E1317-1099-4056-9E03-BA1BA299AA4BQ37147591-D16E85C1-0AAF-47D8-9F5C-E693A84BFF32Q37318591-537EFB27-710F-4551-A2ED-31EB1852D7A7Q37321948-EDC503BA-D780-4247-BD50-74561F9B50C2Q37341217-225F4B9A-8C9E-4D79-8A83-6FF532235811
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Epidemiology of acromegaly.
@ast
Epidemiology of acromegaly.
@en
type
label
Epidemiology of acromegaly.
@ast
Epidemiology of acromegaly.
@en
prefLabel
Epidemiology of acromegaly.
@ast
Epidemiology of acromegaly.
@en
P356
P1433
P1476
Epidemiology of acromegaly.
@en
P2093
Holdaway IM
Rajasoorya C
P2888
P356
10.1023/A:1009965803750
P577
1999-06-01T00:00:00Z
P6179
1032354814